Johnson & Johnson JNJ
NYSE JNJ
$267.67 -5.77 (-2.11%)
At close: Aug 20, 2026 · 4:00 PM EDT

Johnson & Johnson (JNJ) Total Current Liabilities (2009 - 2026)

Johnson & Johnson (JNJ) posted Total Current Liabilities of $54.9 billion for Q2 2026, down 4.89% sequentially from $57.7 billion in Q1 2026, and up 1.32% YoY from $54.2 billion in Q2 2025.

Johnson & Johnson (JNJ) Total Current Liabilities (2009 - 2026) Analysis & Trends

Johnson & Johnson has reported Total Current Liabilities for 18 years, with the latest figure at $54.9 billion in Q2 2026.

  • Quarterly Total Current Liabilities rose 1.32% year-over-year to $54.9 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $54.9 billion (up 1.32% YoY) and the FY2025 annual result came in at $54.1 billion, up 7.56% from the prior year.
  • Total Current Liabilities retreated to $54.9 billion in Q2 2026 per JNJ's latest filing, from $57.7 billion in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $60.4 billion in Q2 2023 and troughed at $43.4 billion in Q2 2022.
  • A 5-year average of $51.2 billion and a median of $51.8 billion in 2024 frame the typical range for Total Current Liabilities.
  • The sharpest annual moves came in 2023 and 2024: Total Current Liabilities jumped 39.14% in 2023, then fell 19.29% in 2024.
  • Over 5 years, Total Current Liabilities stood at $45.5 billion in 2022, then grew by 1.62% to $46.3 billion in 2023, then increased by 8.73% to $50.3 billion in 2024, then climbed by 7.56% to $54.1 billion in 2025, then grew by 1.42% to $54.9 billion in 2026.
  • According to Business Quant data, Total Current Liabilities over the past three periods registered $54.9 billion, $57.7 billion, and $54.1 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 645.88 Bn 625.12 Bn 17.26 Bn 54.90 Bn
2 AbbVie 463.46 Bn 456.89 Bn 12.70 Bn 41.64 Bn
3 Merck 367.92 Bn 360.78 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 297.71 Bn 290.02 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 255.55 Bn 250.65 Bn 12.86 Bn 31.55 Bn
6 Amgen 234.52 Bn 220.53 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 178.22 Bn 175.04 Bn 6.22 Bn 11.02 Bn
8 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn 32.65 Bn
9 Gsk 105.32 Bn 101.15 Bn 8.24 Bn -28.89 Bn
10 Sanofi 54.20 Bn 46.82 Bn 10.79 Bn 37.11 Bn

Historic Data

Download Data
DateValue
Jun 28, 2026 54.90 Bn
Mar 29, 2026 57.72 Bn
Dec 28, 2025 54.13 Bn
Sep 28, 2025 50.87 Bn
Jun 29, 2025 54.18 Bn
Mar 30, 2025 56.90 Bn
Dec 29, 2024 50.32 Bn
Sep 29, 2024 51.76 Bn
Jun 30, 2024 53.93 Bn
Mar 31, 2024 48.73 Bn
Dec 31, 2023 46.28 Bn
Oct 1, 2023 44.37 Bn
Jul 2, 2023 54.17 Bn
Apr 2, 2023 60.37 Bn
Jan 1, 2023 55.80 Bn
Oct 2, 2022 45.54 Bn
Jul 3, 2022 44.82 Bn
Apr 3, 2022 43.39 Bn
Jan 2, 2022 45.23 Bn
Oct 3, 2021 44.56 Bn